{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T09:10:03Z","timestamp":1684314603447},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2001,10,1]],"date-time":"2001-10-01T00:00:00Z","timestamp":1001894400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Obes"],"published-print":{"date-parts":[[2001,10]]},"DOI":"10.1038\/sj.ijo.0801717","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T16:33:08Z","timestamp":1032453188000},"page":"1450-1453","source":"Crossref","is-referenced-by-count":10,"title":["Additive effects on rat brain 5HT release of combining phentermine with dexfenfluramine"],"prefix":"10.1038","volume":"25","author":[{"given":"MR","family":"Prow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Lancashire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Aspley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DJ","family":"Heal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"IC","family":"Kilpatrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2001,10,23]]},"reference":[{"key":"BF0801717_CR1","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1093\/oxfordjournals.bmb.a011620","volume":"53","author":"N Finer","year":"1997","unstructured":"Finer N . Obesity. Present and future pharmacological approaches Br Med Bull 1997 53: 409\u2013432.","journal-title":"Br Med Bull"},{"key":"BF0801717_CR2","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0014-2999(75)90265-4","volume":"34","author":"R Samanin","year":"1975","unstructured":"Samanin R, Bernasconi S, Garattini S . The effect of selective lesioning of brain catecholamine-containing neurons on the activity of various anorectics in the rat Eur J Pharmac 1975 34: 373\u2013375.","journal-title":"Eur J Pharmac"},{"key":"BF0801717_CR3","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/j.1552-4604.1997.tb04323.x","volume":"37","author":"M Weiser","year":"1997","unstructured":"Weiser M, Frishman WH, Michaelson MD, Abdeen MA . The pharmacologic approach to the treatment of obesity J Clin Pharmac 1997 37: 453\u2013473.","journal-title":"J Clin Pharmac"},{"key":"BF0801717_CR4","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1345\/aph.17039","volume":"32","author":"J Cerulli","year":"1998","unstructured":"Cerulli J, Lomaestro BM, Malone M . Update on the pharmacotherapy of obesity Ann Pharmacother 1998 32: 88\u2013102.","journal-title":"Ann Pharmacother"},{"key":"BF0801717_CR5","first-page":"581","volume":"283","author":"C Gundlah","year":"1997","unstructured":"Gundlah C, Martin KF, Heal DJ, Schott J, Auerbach SB . In vivo criteria to differentiate monoamine reuptake inhibitors from releasing agents; sibutramine is a reuptake inhibitor J Pharmac Exp Ther 1997 283: 581\u2013591.","journal-title":"J Pharmac Exp Ther"},{"issue":"Suppl 1","key":"BF0801717_CR6","first-page":"S18","volume":"22","author":"DJ Heal","year":"1998","unstructured":"Heal DJ, Aspley S, Prow MR, Jackson HC, Martin KF, Cheetham SC . Sibutramine: a novel anti-obesity drug. A review of the pharmacological evidence to differentiate it from D-amphetamine and d-fenfluramine Int J Obes Relat Metab Disord 1998 22 (Suppl 1): S18\u2013S28.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"BF0801717_CR7","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/clpt.1992.68","volume":"51","author":"M Weintraub","year":"1992","unstructured":"Weintraub M . Long-term weight control: the National Heart, Lung, and Blood Institute funded multimodel intervention study Clin Pharmac Ther 1992 51: 581\u2013646.","journal-title":"Clin Pharmac Ther"},{"key":"BF0801717_CR8","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/S0146-2806(99)90013-0","volume":"24","author":"HM Connolly","year":"1999","unstructured":"Connolly HM, McGoon MD . Obesity drugs and the heart Curr Probl Cardiol 1999 24: 751\u2013792.","journal-title":"Curr Probl Cardiol"},{"key":"BF0801717_CR9","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1001\/jama.283.13.1703","volume":"283","author":"JM Gardin","year":"2000","unstructured":"Gardin JM, Schumacher D, Constantine G, Davis KD, Leung C, Reid CL . Valvular abnormalities and cardiovascular status following exposure to dexfenfluramine or phentermine\/fenfluramine JAMA 2000 283: 1703\u20131709.","journal-title":"JAMA"},{"key":"BF0801717_CR10","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1161\/01.CIR.92.4.790","volume":"92","author":"PA Robiolio","year":"1995","unstructured":"Robiolio PA, Rigolin VH, Wilson JS, Harrison JK, Sanders LL, Bashore TM, Feldman JM . Carcinoid heart disease. Correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography Circulation 1995 92: 790\u2013795.","journal-title":"Circulation"},{"key":"BF0801717_CR11","first-page":"75","volume":"57","author":"LW Fitzgerald","year":"2000","unstructured":"Fitzgerald LW, Burn TC, Brown BS, Patterson JP, Corjay MH, Valentine PA, Sun J-H, Link JR, Abbaszade I, Hollis JM, Largent BL, Hartig PR, Hollis GF, Meunier PC, Robichaud AJ, Robertson DW . Possible role of valvular serotonin 5-HT2B receptors in the cardiopathy associated with fenfluramine Mol Pharmac 2000 57: 75\u201381.","journal-title":"Mol Pharmac"},{"key":"BF0801717_CR12","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/sj.bjp.0702067","volume":"125","author":"DJ Heal","year":"1998","unstructured":"Heal DJ, Cheetham SC, Prow MR, Martin KF, Buckett WR . A comparison of the effects on central 5HT function of sibutramine hydrochloride and other weight-modifying agents Br J Pharmac 1998 125: 301\u2013308.","journal-title":"Br J Pharmac"},{"key":"BF0801717_CR13","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1007\/s002130050296","volume":"131","author":"M Shoaib","year":"1997","unstructured":"Shoaib M, Baumann MH, Rothman RB, Goldberg SR, Schindler CW . Behavioral and neurochemical characteristics of phentermine and fenfluramine administered separately and as a mixture in rats Psychopharmacology 1997 131: 296\u2013306.","journal-title":"Psychopharmacology"},{"key":"BF0801717_CR14","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1161\/01.CIR.100.8.869","volume":"100","author":"RB Rothman","year":"1999","unstructured":"Rothman RB, Ayestas MA, Dersch CM, Baumann MH . Aminorex, fenfluramine, and chlorphentermine and serotonin transporter substrates. Implications for primary pulmonary hypertension Circulation 1999 100: 869\u2013875.","journal-title":"Circulation"},{"key":"BF0801717_CR15","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/(SICI)1098-2396(200005)36:2<102::AID-SYN3>3.0.CO;2-#","volume":"36","author":"MH Baumann","year":"2000","unstructured":"Baumann MH, Ayestas MA, Dersch CM, Brockington A, Rice KC, Rothman RB . Effects of phentermine and fenfluramine on extracellular dopamine and serotonin in rat nucleus accumbens: therapeutic implications Synapse 2000 36: 102\u2013113.","journal-title":"Synapse"},{"key":"BF0801717_CR16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0006-8993(98)01003-8","volume":"813","author":"A Balcioglu","year":"1998","unstructured":"Balcioglu A, Wurtman RJ . Effects of fenfluramine and phentermine (fen-phen) on dopamine and serotonin release in rat striatum: in vivo microdialysis study in conscious animals Brain Res 1998 813: 67\u201372.","journal-title":"Brain Res"},{"issue":"Suppl A","key":"BF0801717_CR17","first-page":"143P","volume":"12","author":"B Lancashire","year":"1998","unstructured":"Lancashire B, Viggers J, Prow MR, Aspley S, Martin KF, Cheetham SC, Heal DJ . Monoamine release and uptake inhibition profiles of antiobesity agents J Psychopharmac 1998 12 (Suppl A): 143P.","journal-title":"J Psychopharmac"},{"key":"BF0801717_CR18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0006-8993(90)90192-E","volume":"528","author":"FF Matos","year":"1990","unstructured":"Matos FF, Rollema H, Basbaum AI . Characterization of monoamine release in the lateral hypothalamus of awake, freely moving rats using in vivo microdialysis Brain Res 1990 528: 39\u201347.","journal-title":"Brain Res"},{"key":"BF0801717_CR19","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/BF00166940","volume":"347","author":"P Celada","year":"1993","unstructured":"Celada P, Artigas F . Monoamine oxidase inhibitors increase preferentially extracellular 5-hydroxytryptamine in the midbrain raphe nuclei. A brain microdialysis study in the awake rat Naunyn-Schmiedeberg's Arch Pharmac 1993 347: 583\u2013590.","journal-title":"Naunyn-Schmiedeberg's Arch Pharmac"},{"key":"BF0801717_CR20","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/S0006-2952(00)00306-3","volume":"59","author":"IH Ulus","year":"2000","unstructured":"Ulus IH, Maher TJ, Wurtman RJ . Characterization of phentermine and related compounds as monoamine oxidase (MAO) inhibitors Biochem Pharmac 2000 59: 1611\u20131621.","journal-title":"Biochem Pharmac"},{"key":"BF0801717_CR21","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1038\/sj.ijo.0801732","volume":"25","author":"IC Kilpatrick","year":"2001","unstructured":"Kilpatrick IC, Traut M, Heal DJ . Monoamine oxidase inhibition is unlikely to be relevant to the risks associated with phentermine and fenfluramine: a comparison with their abilities to evoke monoamine release Int J Obes Relat Metab Disord 2001 25: 1454\u20131458.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"BF0801717_CR22","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/j.1476-5381.1975.tb07395.x","volume":"53","author":"W Buczko","year":"1975","unstructured":"Buczko W, De Gaetano G, Garattini S . Effect of fenfluramine on 5-hydroxytryptamine uptake and release by rat blood platelets Br J Pharmac 1975 53: 563\u2013568.","journal-title":"Br J Pharmac"},{"key":"BF0801717_CR23","first-page":"155P","volume":"129","author":"EL Lane","year":"2000","unstructured":"Lane EL, Prow MR, Aspley S, Kilpatrick IC, Heal DJ . d-Fenfluramine releases 5HT from whole blood of rats as measured by in vitro microdialysis Br J Pharmac 2000 129: 155P.","journal-title":"Br J Pharmac"},{"key":"BF0801717_CR24","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/0024-3205(94)00663-6","volume":"55","author":"P Celada","year":"1994","unstructured":"Celada P, Mart\u00edn F, Artigas F . Effects of chronic treatment with dexfenfluramine on serotonin in rat blood, brain and lung tissue Life Sci 1994 55: 1237\u20131243.","journal-title":"Life Sci"},{"key":"BF0801717_CR25","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S0002-9149(99)00896-6","volume":"85","author":"RB Rothman","year":"2000","unstructured":"Rothman RB, Redmon JB, Raatz SK, Kwong CA, Swanson JE, Bantle JP . Chronic treatment with phentermine combined with fenfluramine lowers plasma serotonin Am J Cardiol 2000 85: 913\u2013915.","journal-title":"Am J Cardiol"},{"key":"BF0801717_CR26","first-page":"S51","volume":"11","author":"SF Leibowitz","year":"1988","unstructured":"Leibowitz SF, Weiss GF, Shor-Posner G . Hypothalamic serotonin: pharmacological, biochemical, and behavioural analyses of its feeding-suppressive action Clin Neuropharmac 1988 11: S51\u2013S71.","journal-title":"Clin Neuropharmac"}],"container-title":["International Journal of Obesity"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/0801717.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/0801717","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/0801717.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T07:19:19Z","timestamp":1684221559000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/0801717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,10]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2001,10]]}},"alternative-id":["BF0801717"],"URL":"https:\/\/doi.org\/10.1038\/sj.ijo.0801717","relation":{},"ISSN":["0307-0565","1476-5497"],"issn-type":[{"value":"0307-0565","type":"print"},{"value":"1476-5497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,10]]}}}